[Changes in the prolactin and thyrotropin content as affected by thyroliberin in patients with polycystic ovaries].
D001971:Bromocriptine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D010052:Ovariectomy; D011085:Polycystic Ovary Syndrome / Q000097:blood* / Q000628:therapy; D011388:Prolactin / Q000097:blood*; D013963:Thyroid Hormones / Q000627:therapeutic use; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone; D013997:Time Factors
D013963:Thyroid Hormones; D001971:Bromocriptine; D013973:Thyrotropin-Releasing Hormone; C004227:thyroidin; D011388:Prolactin; D013972:Thyrotropin
Izmenenie soderzhaniia prolaktina i tireotropina pod vliianiem tiroliberina u bol'nykh s polikistoznymi iaichnikami.